Hospital Clinic of Barcelona — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Hospital Clinic of Barcelona appears in 129 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials129

Recruiting shown5

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Comparison of Two Surgical Techniques for Treatment of Type III Obesity (BMI 40-50 kg/m2): Single Anastomosis Duodenoileal Bypass With Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.NCT06789965 · lead sponsor · 2025-02-01

Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer PatientsNCT07107594 · lead sponsor · 2025-01-14

Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP TrialNCT06314477 · lead sponsor · 2024-02-29

Conduction System Pacing vs Biventricular Pacing in Systolic Dysfunction and Wide QRS: Mortality, Heart Failure Hospitalization or Cardiac TransplantNCT06105580 · lead sponsor · 2023-11-27

Multimodal Prehabilitation in Patients with Lung Cancer Undergoing Neoadjuvant TherapyNCT05636969 · lead sponsor · 2023-06-10

Engage-PD: a Physical Activity Coaching Program Via Telehealth for People With Parkinson's Disease. A Single-cohort Study in Spain.NCT07859332 · lead sponsor · 2027-06-01

NOT_YET_RECRUITING

Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Women With Gestational DiabetesNCT07558291 · lead sponsor · 2026-10-01

NOT_YET_RECRUITING

Algorithm-Based Timing of Delivery Using the sFlt-1/PlGF Ratio in Early-Onset Severe Preeclampsia. (MAP 2 Study : Management Based on Angiogenic Markers in Preeclampsia 2 Study )NCT07665112 · lead sponsor · 2026-07-01

NOT_YET_RECRUITING

Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple SclerosisNCT07028879 · lead sponsor · 2025-03-13

Barcelona Esquerra Glaucoma Artificial Intelligence-based Screening Program (BEGAS)NCT06353542 · lead sponsor · 2024-05-02

Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast CancerNCT06329089 · lead sponsor · 2024-01-01

Quality of Life and Cosmetic Outcomes of Breast-Conserving Surgery According to Localization MethodNCT06186011 · lead sponsor · 2023-10-04

Risk Stratification Using MEESSI-AHF Scale in ED and Impact on AHF OutcomesNCT05919225 · lead sponsor · 2023-06-27

Urban-training Intervention in Pulmonary Hypertension (UTHAP)NCT05523557 · lead sponsor · 2023-02-01

Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.NCT05553327 · lead sponsor · 2022-05-31

Artificial Pancreas With Carbohydrate Suggestion for Patients With Type 1 Diabetes Prone to HypoglycemiaNCT05628662 · lead sponsor · 2021-10-22

Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial InfarctionNCT06619600 · lead sponsor · 2021-05-30

Treating Early Stages With an Intervention Targeting Cognitive ReserveNCT05288049 · lead sponsor · 2021-01-01

Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery OutcomesNCT04727411 · lead sponsor · 2021-01-01

Effect of Protein Supplementation and a Structured Exercise Program on Muscle in Women After Bariatric Surgery.NCT04771377 · lead sponsor · 2020-11-10

Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser TherapyNCT04619485 · lead sponsor · 2020-10-30

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer SurvivorsNCT04705883 · lead sponsor · 2020-09-01

Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label StudyNCT04233372 · lead sponsor · 2020-08-27

Ambulatory Blood Pressure in HFPEF Outcomes Global RegistryNCT04065620 · lead sponsor · 2020-03-01

Acute Post-cardiac Surgery Renal Failure: Prevention Through Individualized Intensive Hemodynamic ManagementNCT04005105 · lead sponsor · 2019-10-14

Multimodal Prehabilitation in Thoracic SurgeryNCT04052100 · lead sponsor · 2019-10-01

Prediction and Prevention of Nocturnal Hypoglycemia in Persons With Type 1 Diabetes Using Machine Learning TechniquesNCT03711656 · lead sponsor · 2018-10-10

Enhancing Cognitive Reserve of the Offsprings of Bipolar and Schizophrenic PatientsNCT03722082 · lead sponsor · 2018-10-01

Efficacy of an App for Monitoring Physical Activity and Weight of Obese Pregnant Women (Pas&Pes)NCT03706872 · lead sponsor · 2018-07-01

Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary HypertensionNCT03550729 · lead sponsor · 2018-07-01

SAFE-AP: Automatic Control of Blood Glucose Under Announced and Unannounced ExerciseNCT03577158 · lead sponsor · 2018-06-01

Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary DiseaseNCT04803695 · lead sponsor · 2018-03-01

Multidisciplinary Treatment of Obesity Prior to in Vitro Fertilization: Impact on Global Reproductive Outcomes (PRO-FIV Study)NCT03395067 · lead sponsor · 2018-01-28

Changes in the Retinal and Carotid Microcirculation After Restoring Normoglycemia in Patients With Type 2 DiabetesNCT03594591 · lead sponsor · 2018-01-02

Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes MellitusNCT03422965 · lead sponsor · 2017-05-08

Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)NCT02904733 · lead sponsor · 2017-04-07

Cognitive Behavioral Social Skills Training in Early Onset PsychosisNCT03261557 · lead sponsor · 2017-02-22

Cognitive Remediation Therapy in Schizophrenia: Effects on EpigeneticsNCT04278027 · lead sponsor · 2017-01-03

Mediterranean Diet and Bacterial Translocation and Immune-activation in Patients With HIVNCT03846206 · lead sponsor · 2016-07-01

Sentinel Node After Neoadjuvancy In Node-Positive Breast CancerNCT04865549 · lead sponsor · 2016-06-01

Evaluation of an Innovative Information, Training and Social Support Intervention "INFOSADEM" to Principal Caregivers of Dementia Patients Living at HomeNCT04036955 · lead sponsor · 2016-03-01

Pulmonary Gas Exchange Response to Indacaterol in COPDNCT02547558 · lead sponsor · 2015-10-01

Dyspnea in COPD: Relationship With Exacerbations FrequencyNCT02113839 · lead sponsor · 2014-04-01

Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-BNCT01923610 · lead sponsor · 2013-09-01

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)NCT01576731 · lead sponsor · 2012-07-01

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)NCT01533272 · lead sponsor · 2012-02-01

Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF LevelsNCT02341131 · lead sponsor · 2012-01-01

Carotid Atherosclerosis In Newly Diagnosed Type 2 IndividualsNCT01898572 · lead sponsor · 2012-01-01

Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and CirrhosisNCT01409356 · lead sponsor · 2011-10-01

A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAARTNCT01571466 · lead sponsor · 2011-09-01

HVPG for Rebleeding Risk StratificationNCT01751191 · lead sponsor · 2011-08-01

Benefits of CTO-PCI in Selected Cases With HFrEF (CTOHFrEF)NCT02570087 · lead sponsor · 2011-07-01

Spanish Atrial Fibrillation And Resynchronization StudyNCT01181414 · lead sponsor · 2010-10-01

Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.NCT01258374 · lead sponsor · 2010-05-01

Self-expandable Esophageal Stent Versus Balloon Tamponade in Refractory Esophageal Variceal Bleeding.NCT01242280 · lead sponsor · 2010-01-01

Evaluation of Alternative Antimalarial Drugs for Malaria in PregnancyNCT00811421 · lead sponsor · 2009-09-01

ECG Optimization of CRT: Evaluation of Mid-term ResponseNCT01439529 · lead sponsor · 2009-04-01

Bone Marrow Autotransplantation in Type 1 DiabetesNCT00821899 · lead sponsor · 2009-01-01

Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral SuppressionNCT00787774 · lead sponsor · 2008-11-01

Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in CirrhosisNCT01408966 · lead sponsor · 2008-08-01

Drugs studied in this sponsor's trials

16 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Hospital Clinic of Barcelona as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo8

raltegravir2

sildenafil2

calcifediol Oral Capsule1

cholecalciferol1

dapagliflozin1

darunavir1

Delstrigo1

placebo RxCUI 8375 · Lead sponsor in 6 linked trial(s) · 0 currently recruiting 8 trials raltegravir RxCUI 719872 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials sildenafil RxCUI 136411 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials calcifediol Oral Capsule RxCUI 366196 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial cholecalciferol RxCUI 2418 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin RxCUI 1488564 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial darunavir RxCUI 460132 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial Delstrigo RxCUI 2055774 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial enfuvirtide RxCUI 139896 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial fluticasone RxCUI 41126 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial indacaterol RxCUI 1114326 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial insulin, regular, human RxCUI 253182 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial mefloquine RxCUI 6694 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial mirabegron RxCUI 1300786 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial romidepsin RxCUI 877510 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial simvastatin RxCUI 36567 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor85

collaborator44

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.